Administer EMEND for injection as an intravenous infusion on Day 1 over 20 to 30 minutes approximately 30 minutes prior to chemotherapy. *Administer dexamethasone 30 minutes …

EMEND (fosaprepitant dimeglumine) for Injection (115 mg) is a prodrug of aprepitant and may be substituted for oral EMEND (125 mg), 30 minutes prior to chemotherapy, on Day 1 only of the …

Oral administration of EMEND in combination with ondansetron and dexamethasone (aprepitant regimen) has been shown to prevent acute and delayed nausea and vomiting associated with …

2003年3月26日 · NDA/Supplement Number: 207865 and 21549 / 25 Drug Name: EMEND™ (Aprepitant) 25 mg Capsule & Powder for Suspension … 21549 and 207865 to fulfill the PREA …

2023年10月2日 · Emend oral suspension (liquid) can be given to adults and children as young as 6 months old. Aprepitant belongs to a class of medications called antiemetics. Emend works …

2018年3月26日 · EMEND® for injection, in combination with other antiemetic agents, is indicated in adults for the prevention of: acute and delayed nausea and vomiting associated with initial …

postmarketing adverse event reports with a serious outcome for Emend (aprepitant) capsules and oral suspension in pediatric patients. This review was triggered by the pediatric indications for

2016年2月4日 · today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for single-dose EMEND ® …

EMEND capsules or EMEND for oral suspension may be used as an alternative on Days 2 and 3. Administer EMEND for injection through a central venous catheter as an intravenous infusion …

2015年9月2日 · approved a supplemental New Drug Application (sNDA) for EMEND ® (aprepitant) capsules, a substance P/neurokinin 1 (NK1) receptor antagonist. With this …